Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
2.690
-0.100 (-3.58%)
Nov 21, 2024, 4:00 PM EST - Market closed
Inozyme Pharma Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$16.14
Upside
+500.00%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +420.45% | Nov 6, 2024 |
Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +755.02% | Nov 6, 2024 |
Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +755.02% | Oct 25, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +420.45% | Oct 25, 2024 |
Wedbush | Wedbush | Buy Reiterates $15 | Buy | Reiterates | $15 | +457.62% | Sep 30, 2024 |
Stifel | Stifel | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +494.80% | Sep 12, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $16 → $17 | Strong Buy | Initiates | $16 → $17 | +531.97% | Aug 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +420.45% | Aug 8, 2024 |
Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +755.02% | Aug 6, 2024 |
Wedbush | Wedbush | Buy Reiterates $15 | Buy | Reiterates | $15 | +457.62% | Jul 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +420.45% | Jul 2, 2024 |
Wells Fargo | Wells Fargo | Buy Initiates $14 | Buy | Initiates | $14 | +420.45% | May 30, 2024 |
Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +755.02% | May 8, 2024 |
Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +755.02% | Apr 10, 2024 |
Needham | Needham | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +755.02% | Apr 9, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $16 → $14 | Strong Buy | Maintains | $16 → $14 | +420.45% | Apr 9, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.